As previously stated, the EGOI-PCOS has proposed a formal reclassification of PCOS, with a separation of typically insulin resistant-hyperandrogenic PCOS patients, and typically normoandrogenic PCOS patients who do not typically demonstrate insulin dysfunction. This evidence concerns the gene INS and polycystic ovary syndrome.